Withholding primary PcP prophylaxis in virologically suppressed HIV patients: An emulation of a pragmatic trial in COHERE
Articolo
Data di Pubblicazione:
2021
Citazione:
Withholding primary PcP prophylaxis in virologically suppressed HIV patients: An emulation of a pragmatic trial in COHERE / Atkinson, A; Zwahlen, M; Barger, D; D'Arminio Monforte, A; De Wit, S; Ghosn, J; Girardi, E; Svedhem-Johansson, V; Morlat, P; Mussini, C; Noguera-Julian, A; Stephan, C; Touloumi, G; Kirk, O; Mocroft, A; Reiss, P; Miro, J M; Carpenter, J R; Furrer, H. - In: CLINICAL INFECTIOUS DISEASES. - ISSN 1058-4838. - 73:2(2021), pp. 195-202. [10.1093/cid/ciaa615]
Abstract:
Using data from the COHERE collaboration, we investigated whether primary prophylaxis for Pneumocystis Pneumonia (PcP) might be withheld in all patients on antiretroviral therapy with suppressed plasma HIV RNA (≤ 400c/mL) irrespective of CD4 count.
Tipologia CRIS:
Articolo su rivista
Keywords:
HIV-RNA; human immunodeficiency virus; pneumocystis pneumonia; prophylaxis;
Elenco autori:
Atkinson, A; Zwahlen, M; Barger, D; D'Arminio Monforte, A; De Wit, S; Ghosn, J; Girardi, E; Svedhem-Johansson, V; Morlat, P; Mussini, C; Noguera-Julian, A; Stephan, C; Touloumi, G; Kirk, O; Mocroft, A; Reiss, P; Miro, J M; Carpenter, J R; Furrer, H
Link alla scheda completa:
Link al Full Text:
Pubblicato in: